Ccme Global Ltd vs Dr Lalchandani Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of CCME Global Ltd is ₹ 30.22 as of 23 Oct 15:30 . The P/E Ratio of CCME Global Ltd changed from 6.8 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 2 yearsThe P/E Ratio of Dr Lalchandani Labs Ltd changed from 6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of CCME Global Ltd changed from ₹ 12.13 crore on March 2022 to ₹ 447.88 crore on March 2026 . This represents a CAGR of 105.81% over 5 yearsThe Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 6.02 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of CCME Global Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0.04 crore. This represent the decline of -100% The revenue of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of CCME Global Ltd for the Jun '26 is ₹ -0.24 crore as compare to the Mar '26 ebitda of ₹ -0.5 crore. This represent the decline of -52% The ebitda of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of CCME Global Ltd changed from ₹ -0.1 crore to ₹ -0.26 crore over 9 quarters. This represents a CAGR of 52.91% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of CCME Global Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About CCME Global Ltd

Genesis IBRC India Limited was formerly incorporated as Fine Plast Polymers Limited in October, 1992.
Thereafter, the name of the Company was changed from Fine Plast Polymers Limited to SSK Lifestyles Limited in October, 2014 and further was changed from SSK Lifestyles Limited to Genesis IBRC India Limited in January, 2018.
Promoted by P M Rao, P Janardhana Rao, P Rama Rao and their Associates, the Company came out with a public issue in Dec.'93 to part-finance the setting up of its plant in Pamur, Andhra Pradesh.
The plant has an installed capacity of 432 tpa for rigid PVC pipes and 778 tpa for PVC fittings. Initially, Company manufactured rigid PVC pipes and fittings like tees, elbows, adopters, reducers, end caps, etc. used in agriculture and agro-based activities like sprinkler irrigation systems, process piping, oil and gas and shipping industries.

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

FAQs for the comparison of CCME Global Ltd and Dr Lalchandani Labs Ltd

Which company has a larger market capitalization, CCME Global Ltd or Dr Lalchandani Labs Ltd?

Market cap of CCME Global Ltd is 136 Cr while Market cap of Dr Lalchandani Labs Ltd is 6 Cr

What are the key factors driving the stock performance of CCME Global Ltd and Dr Lalchandani Labs Ltd?

The stock performance of CCME Global Ltd and Dr Lalchandani Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for CCME Global Ltd and Dr Lalchandani Labs Ltd?

As of October 25, 2026, the CCME Global Ltd stock price is INR ₹30.22. On the other hand, Dr Lalchandani Labs Ltd stock price is INR ₹6.96.

How do dividend payouts of CCME Global Ltd and Dr Lalchandani Labs Ltd compare?

To compare the dividend payouts of CCME Global Ltd and Dr Lalchandani Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.